+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Veterinary Diagnostic Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 194 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5613052
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The veterinary diagnostic market is rapidly refining its strategic priorities as transformative technologies, evolving regulations, and growing expectations for speed and accuracy shape animal health solutions. Senior decision-makers are navigating a landscape where proactive adaptation, operational flexibility, and collaboration define competitive edge amid shifting market demands.

Veterinary Diagnostic Market Snapshot

The global veterinary diagnostic market experienced growth from USD 3.63 billion in 2024 to USD 3.89 billion in 2025, with a projected CAGR of 7.72% reaching USD 6.59 billion by 2032. This sustained expansion reflects the integration of advanced instrumentation, molecular breakthroughs, and increasing digitalization of laboratory workflows. North America and Asia-Pacific are notable contributors due to strong research capabilities, mature regulations, and rising rates of pet ownership, driving continued advancement and investment. Solution portfolios now cater to both high-throughput laboratory settings and point-of-care environments, empowering organizations to meet a wide range of diagnostic challenges.

Scope & Segmentation of the Veterinary Diagnostic Market

This report delivers a holistic analysis designed for senior leaders seeking strategic clarity in a complex marketplace. Key segmentation areas include:

  • Product Type: Instruments, reagents, software, and services; these also encompass consulting, data management, and specialized training for optimized user outcomes.
  • Animal Type: Focus areas include aquaculture, companion animals, equine, livestock, and poultry, each with distinct diagnostic needs and regulatory requirements.
  • Test Type: Clinical biochemistry, hematology, imaging, immunodiagnostics, microbiology, and molecular diagnostics—serving both routine screening and complex disease identification.
  • Sample Type: Options such as serum and plasma, tissue, urine, and whole blood enable a spectrum of accurate diagnostic procedures.
  • Technology: The market benefits from flow cytometry, immunoassays, next-generation sequencing, and polymerase chain reaction (PCR), accelerating test reliability and versatility.
  • Disease Type: Assessed segments span genetic disorders, infectious diseases including bacterial, fungal, parasitic, and viral, as well as metabolic and neoplastic disorders.
  • End User: Academic and research institutes, diagnostic laboratories, point-of-care settings, and veterinary hospitals each drive unique adoption trends and solution requirements.
  • Region: Analysis extends across the Americas, Europe, Middle East and Africa, and Asia-Pacific, featuring detailed insights for key countries such as the United States, China, Germany, and India.
  • Company Coverage: The report evaluates leading players, such as Zoetis Inc., IDEXX Laboratories, and Thermo Fisher Scientific, highlighting their innovation strategies, acquisitions, and product portfolio expansions.

Key Takeaways for Senior Decision-Makers

  • Digital transformation within veterinary laboratories is optimizing diagnostic workflows and supporting more accurate, data-driven decision-making processes.
  • Companion animal diagnostics are driving overall market momentum, propelled by demand for timely, wellness-oriented testing options, while livestock and poultry segments put a premium on biosecurity and herd health management.
  • Emerging molecular and imaging technologies are advancing early disease identification and enabling greater precision in treatment planning.
  • Strategic partnerships, ongoing R&D investment, and adoption of modular technology platforms are enhancing product lifecycles and strengthening the end-user experience.
  • Geographic diversity brings opportunities for tailored go-to-market strategies, as infrastructure sophistication, regulatory demands, and veterinary practices differ by region.
  • Expanded training, consulting, and post-sale support offerings are increasingly vital for vendors to differentiate and add long-term value for clients navigating evolving animal health landscapes.

Tariff Impact and Supply Chain Adaptation

Introduction of new tariffs by the United States in 2025 has influenced sourcing decisions and supplier negotiations within the veterinary diagnostic supply chain. In response, industry stakeholders are focusing on procurement agility, vendor diversification, and prioritization of regional manufacturing partnerships to sustain cost-effectiveness and supply stability. These strategies are shifting competitive dynamics and elevating the importance of value-added services in supplier selection.

Veterinary Diagnostic Market Methodology & Data Sources

The research leverages secondary sources, industry literature, and regulatory documentation, complemented by primary interviews with professional veterinarians, technology specialists, and regulatory experts. Data triangulation and expert workshops validate findings to offer reliable, actionable guidance tailored for senior leaders focused on empirical evidence and practicality.

Why This Report Matters

  • Provides actionable insights to help executives align innovation, procurement, and regional growth initiatives with evolving market dynamics.
  • Comprehensive segmentation supports optimized decisions on technology adoption, product development, and targeted market entry strategies.
  • The report equips organizations with competitive clarity, equipping leaders to anticipate risks and capitalize on new opportunities within a dynamic animal health environment.

The veterinary diagnostic sector is advancing through the adoption of new technologies, evolving operational models, and increased collaboration. Organizations that leverage these market insights can enhance outcomes and strengthen their competitive positioning as the industry progresses.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Expansion of point-of-care molecular diagnostics for rapid zoonotic disease detection in veterinary clinics
5.2. Integration of artificial intelligence algorithms in veterinary imaging diagnostics for improved accuracy
5.3. Adoption of multi-pathogen multiplex PCR assays in small animal veterinary practice workflows
5.4. Growing use of digital cytology platforms for remote blood smear analysis and teleconsultation services
5.5. Rising demand for portable ultrasound systems enabling on-site livestock health monitoring and screening
5.6. Development of smartphone-based diagnostics for real-time detection of bovine mastitis pathogens on farms
5.7. Implementation of blockchain-enabled traceability systems in veterinary diagnostic supply chains to ensure sample integrity
5.8. Surge in investment toward immunoassay-based point-of-care tests for rapid infectious disease screening in equine care
5.9. Emergence of CRISPR-based point-of-care tests enabling ultra-sensitive detection of animal pathogens
5.10. Use of wearable biosensor collars for continuous monitoring of livestock physiological parameters and early disease onset
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Veterinary Diagnostic Market, by Product Type
8.1. Instruments
8.1.1. Chemistry Analyzers
8.1.2. Hematology Analyzers
8.1.3. Microscopy Systems
8.1.4. PCR Instruments
8.2. Reagents
8.3. Software & Services
8.3.1. Consulting Services
8.3.2. Data Management Software
8.3.3. Training Services
9. Veterinary Diagnostic Market, by Animal Type
9.1. Aquaculture
9.2. Companion Animals
9.3. Equine
9.4. Livestock
9.5. Poultry
10. Veterinary Diagnostic Market, by Test Type
10.1. Clinical Biochemistry
10.2. Hematology
10.3. Imaging
10.4. Immunodiagnostics
10.5. Microbiology
10.6. Molecular Diagnostics
11. Veterinary Diagnostic Market, by Sample Type
11.1. Serum & Plasma
11.2. Tissue
11.3. Urine
11.4. Whole Blood
12. Veterinary Diagnostic Market, by Technology
12.1. Flow Cytometry
12.2. Immunoassays
12.3. Next-Generation Sequencing
12.4. Polymerase Chain Reaction (PCR)
13. Veterinary Diagnostic Market, by Disease Type
13.1. Genetic Disorders
13.2. Infectious Diseases
13.2.1. Bacterial
13.2.2. Fungal
13.2.3. Parasitic
13.2.4. Viral
13.3. Metabolic Disorders
13.4. Neoplastic Disorders
14. Veterinary Diagnostic Market, by End User
14.1. Academic & Research Institutes
14.2. Diagnostic Laboratories
14.3. Point Of Care Testing
14.4. Veterinary Hospitals
15. Veterinary Diagnostic Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Veterinary Diagnostic Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Veterinary Diagnostic Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Zoetis Inc.
18.3.2. Virbac S.A.
18.3.3. IDEXX Laboratories, Inc.
18.3.4. Neogen Corporation
18.3.5. Thermo Fisher Scientific Inc.
18.3.6. QIAGEN N.V.
18.3.7. Bio-Rad Laboratories, Inc.
18.3.8. Agrolabo S.p.A.
18.3.9. Biogal Galed Labs
18.3.10. BioMérieux S.A.
18.3.11. BioNote USA, Inc.
18.3.12. Demeditec Diagnostics GmbH
18.3.13. Eurofins Scientific SE
18.3.14. Fassisi GmbH
18.3.15. FUJIFILM Holdings Corporation
18.3.16. Mars, Incorporated
18.3.17. Promega Corporation
18.3.18. Randox Laboratories, Ltd.
18.3.19. Shenzhen Mindray Animal Medical Technology Co., Ltd.
18.3.20. Vimian Group AB
18.3.21. SAN Group Biotech Germany GmbH
18.3.22. Meridian Bioscience, Inc.
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Veterinary Diagnostic market report include:
  • Zoetis Inc.
  • Virbac S.A.
  • IDEXX Laboratories, Inc.
  • Neogen Corporation
  • Thermo Fisher Scientific Inc.
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • Agrolabo S.p.A.
  • Biogal Galed Labs
  • BioMérieux S.A.
  • BioNote USA, Inc.
  • Demeditec Diagnostics GmbH
  • Eurofins Scientific SE
  • Fassisi GmbH
  • FUJIFILM Holdings Corporation
  • Mars, Incorporated
  • Promega Corporation
  • Randox Laboratories, Ltd.
  • Shenzhen Mindray Animal Medical Technology Co., Ltd.
  • Vimian Group AB
  • SAN Group Biotech Germany GmbH
  • Meridian Bioscience, Inc.

Table Information